Department of Molecular and Cellular Neurobiology, Center for Neurogenomics and Cognitive Research, Neuroscience Campus Amsterdam, VU University, De Boelelaan 1085, 1081 HV Amsterdam, The Netherlands.
Adv Exp Med Biol. 2012;970:469-91. doi: 10.1007/978-3-7091-0932-8_21.
A hallmark of drug addiction is the uncontrollable desire to consume drugs at the expense of severe negative consequences. Moreover, addicts that successfully refrain from drug use have a high vulnerability to relapse even after months or years of abstinence. In this chapter, we will discuss the current understanding of drug-induced neuroplasticity within the mesocorticolimbic brain system that contributes to the development of addiction and the persistence of relapse to drug seeking. I particular, we will focus at animal models that can be translated to human addiction. Although dopaminergic transmission is important for the acute effects of drug intake, the long-lived behavioral abnormalities associated with addiction are thought to arise from pathological plasticity in glutamatergic neurotransmission. The nature of changes in excitatory synaptic plasticity depends on several factors, including the type of drug, the brain area, and the time-point studied in the transition of drug exposure to withdrawal and relapse to drug seeking. Identification of drug-induced neuroplasticity is crucial to understand how molecular and cellular adaptations contribute to the end stage of addiction, which from a clinical perspective, is a time-point where pharmacotherapy may be most effectively employed.
药物成瘾的一个显著特征是,为了满足强烈的负面后果,而无法控制地渴望使用药物。此外,即使在成功戒断药物数月甚至数年后,成瘾者也极易复发。在这一章中,我们将讨论目前对药物引起的中脑边缘奖赏系统神经可塑性的理解,这种神经可塑性有助于成瘾的发展和对药物寻求的持续复发。特别是,我们将关注可转化为人类成瘾的动物模型。虽然多巴胺能传递对药物摄入的急性作用很重要,但与成瘾相关的持久行为异常被认为是谷氨酸能神经传递的病理性可塑性引起的。兴奋性突触可塑性变化的性质取决于几个因素,包括药物类型、大脑区域以及在药物暴露向戒断和复发的转变过程中研究的时间点。识别药物引起的神经可塑性对于理解分子和细胞适应如何导致成瘾的终末阶段至关重要,从临床角度来看,这是药物治疗最有效的时间点。